BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35501727)

  • 21. The Significance of Sidedness in Patients with Metastatic Colorectal Cancer Treated with Triplet First-line Chemotherapy.
    Bazarbashi S; Omar AT; Raddaoui L; Badran A; Alzahrani A; Aljubran A; Elhassan T
    Asian Pac J Cancer Prev; 2019 Oct; 20(10):2891-2896. PubMed ID: 31653131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor Sidedness Is Associated with Survival in Patients with Synchronous Colorectal Peritoneal Carcinomatosis.
    Matsuda K; Tamura K; Iwamoto H; Mizumoto Y; Mitani Y; Nakamura Y; Murakami D; Sakanaka T; Yamaue H
    Oncology; 2020; 98(4):230-236. PubMed ID: 31962336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors of patients with left-sided obstructive colorectal cancer: post hoc analysis of a retrospective multicenter study by the Japan Colonic Stent Safe Procedure Research Group.
    Endo S; Isohata N; Kojima K; Kadono Y; Amano K; Otsuka H; Fujimoto T; Egashira H; Saida Y;
    World J Surg Oncol; 2022 Jan; 20(1):24. PubMed ID: 35086523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-world Data for High-risk Stage II Colorectal Cancer - The Role of Tumor Side in the Adjuvant Setting.
    Araujo CS; Venchiarutti Moniz CM; Bonadio RC; Watarai GY; Rojas J; Nogueira PVS; Martinez JK; Moraes PMG; Braghiroli MI; Sabbaga J; Hoff PM
    Clin Colorectal Cancer; 2021 Jun; 20(2):e100-e108. PubMed ID: 33234431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is primary sidedness a prognostic factor in patients with resected colon cancer liver metastases (CLM)?
    Marques MC; C Ribeiro HS; Costa WL; de Jesus VHF; de Macedo MP; Diniz AL; Godoy AL; Farias IC; Aguiar S; Riechelmann RSP; S Begnami MDF; Coimbra FJF
    J Surg Oncol; 2018 Apr; 117(5):858-863. PubMed ID: 29611198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the Prognostic Value of Primary Tumor Location and KRAS in Metastatic Colorectal Cancer: A Post Hoc Analysis of the OPTIMOX3 DREAM Phase III Study.
    Chibaudel B; André T; Tournigand C; Louvet C; Benetkiewicz M; Larsen AK; de Gramont A
    Clin Colorectal Cancer; 2020 Sep; 19(3):200-208.e1. PubMed ID: 32303437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of colorectal screening program on the detection of right-sided colorectal cancer. A 5-year cohort study in the Mantua District.
    Asteria CR; Pucciarelli S; Gerard L; Mantovani N; Pagani M; Boccia L; Ricci P; Troiano L; Lucchini G; Pulica C
    Int J Colorectal Dis; 2015 Dec; 30(12):1627-37. PubMed ID: 26255258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Impact of Primary Tumor Sidedness in Stage III Colorectal Cancer: Real-World Evidence from a Brazilian Cohort.
    Protásio BM; de Castria TB; Natalino R; Mangone FR; Saragiotto DF; Sabbaga J; Hoff PM; Chammas R
    Clin Colorectal Cancer; 2024 Mar; 23(1):73-84. PubMed ID: 38151358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage-based Variation in the Effect of Primary Tumor Side on All Stages of Colorectal Cancer Recurrence and Survival.
    Lee MM; MacKinlay A; Semira C; Schieber C; Jimeno Yepes AJ; Lee B; Wong R; Hettiarachchige CKH; Gunn N; Tie J; Wong HL; Skinner I; Jones IT; Keck J; Kosmider S; Tran B; Field K; Gibbs P
    Clin Colorectal Cancer; 2018 Sep; 17(3):e569-e577. PubMed ID: 29980491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic impact of tumor location in stage IV colon cancer: a propensity score analysis in a multicenter study.
    Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Hashiguchi Y; Sugihara K; Watanabe T
    Int J Surg; 2014; 12(9):925-30. PubMed ID: 25091400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Difference in Time to Locoregional Recurrence Between Patients With Right-Sided and Left-Sided Colon Cancers.
    Park JH; Kim MJ; Park SC; Kim MJ; Hong CW; Sohn DK; Han KS; Oh JH
    Dis Colon Rectum; 2015 Sep; 58(9):831-7. PubMed ID: 26252844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there a prognostic value of tumor location among Chinese patients with colorectal cancer?
    Liu F; Li C; Jia H; Yang L; Wu Y; Zhao J; Cai S; Zhu J; Xu Y
    Oncotarget; 2017 Jun; 8(24):38682-38692. PubMed ID: 28418874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different clinicopathologic features and favorable outcomes of patients with stage III left-sided colon cancer.
    Huang CW; Tsai HL; Huang MY; Huang CM; Yeh YS; Ma CJ; Wang JY
    World J Surg Oncol; 2015 Aug; 13():257. PubMed ID: 26311139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abdominal lymph node recurrence from colorectal cancer: Resection should be considered as a curative treatment in patients with controlled disease.
    Zarzavadjian Le Bian A; Genser L; Tabchouri N; Fillol C; Laforest A; Tresallet C; Ouaissi M; Fuks D
    Surg Oncol; 2020 Dec; 35():206-210. PubMed ID: 32911212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: a nationwide cohort study.
    Chen KH; Shao YY; Chen HM; Lin YL; Lin ZZ; Lai MS; Cheng AL; Yeh KH
    BMC Cancer; 2016 May; 16():327. PubMed ID: 27221731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between Prognosis and Tumor Laterality in Early-Stage Colon Cancer.
    Karim S; Brennan K; Nanji S; Berry SR; Booth CM
    JAMA Oncol; 2017 Oct; 3(10):1386-1392. PubMed ID: 28594974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of tumor location on the biological and oncological differences of colon cancer: Multi-institutional propensity score-matched study.
    Kishiki T; Kuchta K; Matsuoka H; Kojima K; Asou N; Beniya A; Yamauchi S; Sugihara K; Masaki T
    Am J Surg; 2019 Jan; 217(1):46-52. PubMed ID: 30384969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.
    Sasaki K; Margonis GA; Wilson A; Kim Y; Buettner S; Andreatos N; Gani F; Amini N; Spolverato G; Pawlik TM
    Ann Surg Oncol; 2016 Oct; 23(11):3736-3743. PubMed ID: 27352204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score.
    Gasser E; Braunwarth E; Riedmann M; Cardini B; Fadinger N; Presl J; Klieser E; Ellmerer P; Dupré A; Imai K; Malik H; Baba H; Ulmer H; Schneeberger S; Öfner D; Dinnewitzer A; Stättner S; Primavesi F
    PLoS One; 2019; 14(5):e0217411. PubMed ID: 31150437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease recurrence after colorectal cancer surgery in the modern era: a population-based study.
    Qaderi SM; Galjart B; Verhoef C; Slooter GD; Koopman M; Verhoeven RHA; de Wilt JHW; van Erning FN
    Int J Colorectal Dis; 2021 Nov; 36(11):2399-2410. PubMed ID: 33813606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.